Mechanisms for the progression of NAFLD/NASH to liver cancer remain incompletely understood, pathogenesis could involve DNA damage of other loci, inflammatory response, genetic modifiers as PNPLA3 or TM6SF2 or mutations such as the recently reported ACVR2A mutations6,46. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.